Pfizer Inc., Protalix Biotherapeutics, Inc. Wins FDA Nod for Gaucher Disease Drug; Genzyme Corporation Faces Competition

NEW YORK & CARMIEL, Israel--(BUSINESS WIRE)-- Pfizer Inc.(NYSE:PFE - News) and Protalix BioTherapeutics, Inc. (NYSE-AMEX:PLX, TASE:PLX) announced today that the United States (U.S.) Food and Drug…
Read the full story: BioSpace.com Featured News